Securities code: Shanghai Haoyuan Chemexpress Co.Ltd(688131) securities abbreviation: Shanghai Haoyuan Chemexpress Co.Ltd(688131) Announcement No.: 2022027 Shanghai Haoyuan Chemexpress Co.Ltd(688131)
Announcement on the shareholding of the top ten shareholders and the top ten circulating shareholders on the trading day before the issuance of shares and the payment of cash to purchase assets and raise supporting funds
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Shanghai Haoyuan Chemexpress Co.Ltd(688131) (hereinafter referred to as “the company”) intends to purchase 100% equity of YaoYuan Pharmaceutical Chemistry (Shanghai) Co., Ltd. by issuing shares and paying cash, and issue shares to Shanghai Anshu Information Technology Co., Ltd., the controlling shareholder, to raise supporting funds (hereinafter referred to as “the transaction”).
Upon the application of the company, the trading of the company’s shares has been suspended since the opening of the market on February 21, 2022. During the suspension period, the company timely performs the obligation of information disclosure according to relevant regulations. For details, see the company’s website published on the Shanghai Stock Exchange (www.sse. Com. CN.) Announcement of Shanghai Haoyuan Chemexpress Co.Ltd(688131) on planning to issue shares and pay cash to purchase assets and raise supporting funds (Announcement No.: 2022020) and announcement of Shanghai Haoyuan Chemexpress Co.Ltd(688131) on planning to issue shares and pay cash to purchase assets and raise supporting funds (Announcement No.: 2022022).
In accordance with the relevant requirements of the guidelines for self discipline supervision of listed companies on Shanghai Stock Exchange No. 4 – suspension and resumption of trading, the names and holdings of the top 10 shareholders, the names and holdings of the top 10 circulating shareholders, and the total number of shareholders one trading day before the suspension of trading of the company (i.e. February 18, 2022) are disclosed as follows:
1、 Total number of shareholders
As of February 18, 2022, the total number of shareholders of the company is 6650.
2、 Shareholding of top 10 shareholders of the company
Serial number shareholder name shareholding quantity (share) shareholding proportion stock type
（%）
1 Shanghai Anshu Information Technology Co., Ltd. 2448000000 32.93 yuan common stock company
Junxin (Shanghai) equity investment base
Gold Management Co., Ltd. – Su mintou
2 Junxin (Shanghai) industrial upgrading and 548190000 7.37 RMB common stock technology innovation equity investment partnership
Industry (limited partnership)
3. Shanghai Zhenjin high tech service industry creates 518122700 RMB 6.97 common stock investment center (limited partnership)
4. Shanghai Chenxiao Enterprise Management Consulting Co., Ltd. 305000000 RMB 4.10 common stock (limited partnership)
5 Shanghai Jingjia entrepreneurship relay venture capital 3 Guangdong Jushen Logistics Company Limited(001202) 00 4.04 yuan common equity capital center (limited partnership)
6 Shanghai Guohong Medical Health Investment Co., Ltd. 220112900 RMB 2.96 common equity (limited partnership)
7 Shanghai chenmai enterprise management center 200000000 RMB 2.69 ordinary shares (limited partnership)
Guotai Junan Securities Co.Ltd(601211) securities asset management – Investment Promotion
8 bank Guotai Junan Securities Co.Ltd(601211) Junxiang Kechuang 166243100 RMB 2.24 common stock board Shanghai Haoyuan Chemexpress Co.Ltd(688131) 1 strategic placement set
Cooperative asset management plan
Xinyu ChuanLiu Investment Management Co., Ltd
Division 9 – Yichuan liuchangfeng new material 165239900 RMB 2.22 common stock investment partnership (limited liability company)
(partner)
Huangshan hi tech Yida Xin’anjiang specialty
10 Texin venture capital fund (limited 162183400 RMB 2.18 common stock partnership)
3、 Shareholding of top 10 circulating shareholders of the company
Serial number shareholder name shareholding quantity shareholding proportion stock type (share) (%)
1 Industrial And Commercial Bank Of China Limited(601398) – China 68347100 RMB 0.92 common stock European medical health hybrid securities investment fund
Bohai Bank Co., Ltd. – China CITIC construction
2. Investment in medical reform and flexible allocation of hybrid securities investment 55750000 0.75 yuan common stock fund
China Construction Bank Corporation(601939) – Fu
3. China precision medical flexible allocation hybrid securities 43106600 0.58 yuan common stock investment fund
Agricultural Bank Of China Limited(601288) – Mo
4 Stanley Huaxin health industry hybrid certificates 39635200 0.53 yuan common stock bond investment fund
5 China Construction Bank Corporation(601939) – jia35657200 RMB 0.48 common stock real medicine health stock securities investment fund
6 Bank Of China Limited(601988) – China Merchants medical 33043400 0.44 yuan common stock pharmaceutical health industry equity securities investment fund
7 Bank Of China Limited(601988) – Castrol medical 31830600 0.43 RMB common stock health care equity securities investment fund
China Construction Bank Corporation(601939) – up
8. Morgan medical health equity securities investment 27122700 0.36 yuan common stock fund
Industrial And Commercial Bank Of China Limited(601398) – Financial
9tong health industry flexibly allocates hybrid securities 22119000 RMB 0.30 common stock investment fund
10 Industrial And Commercial Bank Of China Limited(601398) – China 18807900 RMB 0.25 common stock European medical innovation equity securities investment fund
The company will timely fulfill the obligation of information disclosure in strict accordance with the requirements of relevant laws and regulations, and the information disclosure media designated by the company is the website of Shanghai Stock Exchange (www.sse. Com. CN) And Shanghai Securities News, China Securities News, securities daily and securities times. All information of the company shall be subject to the announcement published in the above designated media.
There is still great uncertainty in the issue of shares and the payment of cash to purchase assets and raise supporting funds planned by the company. Please pay attention to the subsequent relevant announcements and pay attention to the investment risks.
It is hereby announced.
Shanghai Haoyuan Chemexpress Co.Ltd(688131) board of directors March 5, 2022
